Regenicin

Contact
regenicin.com
+1212518-8474

Regenicin, Inc.

470 Park Avenue South, 16th Floor
10016 New York City
USA
+1212518-8474
regenicin.com
Contact
Profile News
Contact

About Regenicin

Regenicin, Inc. is a clinical-stage company developing next-generation tissue-engineered skin substitutes to restore the qualities of healthy human skin. Regenicin is a publicly traded company, with headquarters in New York, NY.

Read more about Regenicin
Facts about Regenicin
  • Focus : Manufacturer
  • Industry : Pharma

News about Regenicin

Regenicin

27-Aug-2010 | people

Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors

Rubinfeld expected to assist with FDA approval process for autologous cultured skin substitute, PermaDerm(TM)

Read news
Show more news about Regenicin

Here you will find Regenicin, Inc.